Pediatrics
Conference Coverage
Tocilizumab linked to refractory uveitis improvements in some JIA patients
MADRID – Tocilizumab was associated with improved vision in a substantial proportion of 22 children with juvenile...
Conference Coverage
Emapalumab produces major responses in macrophage activation syndrome
MADRID – In systemic juvenile idiopathic arthritis complicated by MAS, new therapy produces rapid complete responses.
Video
Efforts toward producing CNO/CRMO classification criteria show first results
MADRID – Cases are now being accepted for inclusion into a repository that will be used to develop and validate criteria.
Conference Coverage
Booster vaccines found largely safe in children on immunosuppressive drugs
MADRID –
Video
Patients with CAPS still improving on long-term canakinumab
MADRID –
Opinion
Antimalarials in pregnancy and lactation
Most antimalarials appear safe to use during pregnancy, but avoid primaquine. Tell patients to use personal protective measures as well.
From the Journals
When adolescents visit the ED, 10% leave with an opioid
Compared with outpatient clinics, prescription rate is more than six times higher in the emergency department.
From the Journals
Various adjuncts to IVIg help treat coronary artery abnormalities in pediatric Kawasaki disease
Guidelines
New JIA, JIA-associated uveitis guidelines address knowledge gaps
A majority of recommendations in both guidelines are called conditional based on low-quality evidence.
News
Benlysta approved for children with SLE
This approval marks the first medicine in the United States meant to treat systemic lupus erythematous in children.
News from the FDA/CDC
FDA approves new etanercept biosimilar, Eticovo
Eticovo (etanercept-ykro) is the second FDA-approved etanercept biosimilar after Erelzi (etanercept-szzs).